We're a company on the vanguard of tackling the toughest challenges in predictive and personalized healthcare practice. We're answering the health needs of many people by combining therapeutic and diagnostic practice, elevating early detection, and clinical management of diseases. Our team includes first-in-class experts in oncology, neurology, clinical development, and regulatory affairs from around the world. We are working to advance new approaches to treat illness with nuclear medicine. We address illnesses for underserved patients. Several of our development initiatives focus on rare pediatric disease. We also target hard-to-cure conditions such as Parkinson's Disease and Breast Cancer by leveraging our expertise to advance clinical management of these diseases.